These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32985273)
1. Is Masked Hypertension an underlying Cause of Unexplained Left Ventricle Hypertrophy? Yılmaz ÖÇ; Özkan S Clin Exp Hypertens; 2021 Feb; 43(2):138-141. PubMed ID: 32985273 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of prehypertension and masked hypertension rate among clinically normotensive patients. Unsal S; Ozkara A; Albayrak T; Ozturk Y; Beysel S; Kucukler FK Clin Exp Hypertens; 2016; 38(2):218-24. PubMed ID: 26818410 [TBL] [Abstract][Full Text] [Related]
3. Untreated Masked Hypertension and Subclinical Cardiac Damage: A Systematic Review and Meta-analysis. Cuspidi C; Sala C; Tadic M; Rescaldani M; Grassi G; Mancia G Am J Hypertens; 2015 Jun; 28(6):806-13. PubMed ID: 25468808 [TBL] [Abstract][Full Text] [Related]
4. Target organ damage in "white coat hypertension" and "masked hypertension". Kotsis V; Stabouli S; Toumanidis S; Papamichael C; Lekakis J; Germanidis G; Hatzitolios A; Rizos Z; Sion M; Zakopoulos N Am J Hypertens; 2008 Apr; 21(4):393-9. PubMed ID: 18292757 [TBL] [Abstract][Full Text] [Related]
5. Increased masked hypertension prevalence in patients with obesity. Özkan S; Ata N; Yavuz B Clin Exp Hypertens; 2018; 40(8):780-783. PubMed ID: 29420079 [TBL] [Abstract][Full Text] [Related]
6. Mild Left Ventricular Hypertrophy in Middle-Age Male Athletes as a Sign of Masked Arterial Hypertension. Małek ŁA; Jankowska A; Greszata L Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011673 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular mass of persistent masked hypertension in Hong Kong Chinese adolescents: a 4-year follow-up study. Yam MC; So HK; Kwok SY; Lo FC; Mok CF; Leung CK; Yip WK; Sung YT Cardiol Young; 2018 Jun; 28(6):837-843. PubMed ID: 29679988 [TBL] [Abstract][Full Text] [Related]
8. Utility of ambulatory blood pressure monitoring in detection of masked hypertension and risk of hypertension mediated organ damage in normotensive patients with type 2 diabetes mellitus. Gupta H; Vidhale T; Pustake M; Gandhi C; Roy T Blood Press; 2022 Dec; 31(1):50-57. PubMed ID: 35438026 [TBL] [Abstract][Full Text] [Related]
9. Masked hypertension and echocardiographic left ventricular hypertrophy: an updated overview. Cuspidi C; Negri F; Sala C; Mancia G Blood Press Monit; 2012 Feb; 17(1):8-13. PubMed ID: 22183044 [TBL] [Abstract][Full Text] [Related]
10. Incident Left Ventricular Hypertrophy in Masked Hypertension. Cuspidi C; Facchetti R; Quarti-Trevano F; Sala C; Tadic M; Grassi G; Mancia G Hypertension; 2019 Jul; 74(1):56-62. PubMed ID: 31104565 [TBL] [Abstract][Full Text] [Related]
11. Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. Di Salvo G; Castaldi B; Baldini L; Gala S; del Gaizo F; D'Andrea A; Limongelli G; D'Aiello AF; Scognamiglio G; Sarubbi B; Pacileo G; Russo MG; Calabrò R J Hum Hypertens; 2011 Dec; 25(12):739-45. PubMed ID: 21228825 [TBL] [Abstract][Full Text] [Related]
12. Nocturnal systolic hypertension is a risk factor for cardiac damage in the untreated masked hypertensive patients. Li J; Cao Y; Liu C; Li J; Yao F; Dong Y; Huang H J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1666-1674. PubMed ID: 31556221 [TBL] [Abstract][Full Text] [Related]
13. Masked hypertension is associated with end organ damage in geriatric age: Geriatric MASked Hypertension and End organ damage (G-MASH-End organ Study). Esme M; Asil S; Yavuz B; Balci C; Kılıç MK; Kızılarslanoğlu MC; Doğan Varan H; Tuna Doğrul R; Halil M; Cankurtaran M; Yavuz BB Blood Press; 2020 Apr; 29(2):80-86. PubMed ID: 31607165 [No Abstract] [Full Text] [Related]
14. Left ventricular mass independently associates with masked hypertension in young healthy adults: the African-PREDICT study. Sekoba NP; Kruger R; Labuschagne P; Schutte AE J Hypertens; 2018 Aug; 36(8):1689-1696. PubMed ID: 29601412 [TBL] [Abstract][Full Text] [Related]
15. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Chung J; Robinson C; Sheffield L; Paramanathan P; Yu A; Ewusie J; Sanger S; Mitsnefes M; Parekh RS; Sinha MD; Rodrigues M; Thabane L; Dionne J; Chanchlani R Hypertension; 2023 Nov; 80(11):2280-2292. PubMed ID: 37737026 [TBL] [Abstract][Full Text] [Related]
17. [Changes in left ventricular geometry in children and adolescents with primary hypertension]. Rucki S Cas Lek Cesk; 2000 Apr; 139(8):240-4. PubMed ID: 10916213 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of masked hypertension and its association with left ventricular hypertrophy in children and young adults with chronic kidney disease: a systematic review and meta-analysis. Goulas I; Evripidou K; Doundoulakis I; Kollios K; Nika T; Chainoglou A; Kotsis V; Stabouli S J Hypertens; 2023 May; 41(5):699-707. PubMed ID: 36883474 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Mancia G; Carugo S; Grassi G; Lanzarotti A; Schiavina R; Cesana G; Sega R; Hypertension; 2002 Mar; 39(3):744-9. PubMed ID: 11897756 [TBL] [Abstract][Full Text] [Related]
20. Masked hypertension and cardiac remodeling in middle-aged endurance athletes. Trachsel LD; Carlen F; Brugger N; Seiler C; Wilhelm M J Hypertens; 2015 Jun; 33(6):1276-83. PubMed ID: 25668355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]